Preventive Cardiovascular Nurses Association
PCNA Login
Preventing Cardiovascular Disease
through continuing education, clinical tools and national health initiatives.
The current state of healthcare demands that nurses play a leading role in cardiovascular risk reduction.
Late Breaking News RSS newsfeed
- Missouri's Roy Blunt heads up GOP effort on healthcare reform - St. Louis Post-Dispatch
- ACC aghast at proposed cuts to cardiology payments in Medicare physician fee schedule for 2010
- Revisions to Health Bill Are Unveiled by Democrats - New York Times
- Clinical Trial Summary: Maximizing Patient Benefit From Cardiac Resynchronization Therapy With the Addition of Structured Exercise Training (Maximizing Patient Benefit From Cardiac Resynchronization Therapy With the Addition of Structured Exercise Training)
- Journal Scan: A Randomised, Controlled Study of Rate Versus Rhythm Control in Patients With Chronic Atrial Fibrillation and Heart Failure: (CAFÉ-II Study) (Heart 2009;95:924-930. )
- Warnings for smoking-cessation drugs varenicline, bupropion
- FDA approves dronedarone for atrial fibrillation
- ARMYDA-RECAPTURE published: Statin reload before PCI
- Journal Scan: Rapid Emergency Department Heart Failure Outpatients Trial (REDHOT II): A Randomized Controlled Trial of the Effect of Serial BNP Testing on Patient Management (Circ Heart Fail 2009;May 19:[Epub ahead of print].)
- Survival after in-hospital CPR static since 1992
- Progenitor cells identified from human fetal hearts
- Barriers to optimal termination of resuscitation in out-of-hospital cardiac arrest identified
- New meta-analysis: Statins of benefit in primary prevention
- CRP, other biomarkers, not clinically useful to predict CVD risk
- Alogliptin delayed; cancer concerns with insulin glargine
- Cardiac rhythms synchronize with music
- Anxiety, depression, linked to angina frequency
- Mainly medical unknowns regarding Michael Jackson's apparent cardiac arrest
- Massive vitamin-D/omega-3 trial for CVD, cancer prevention
- Wolves in sheep's clothing: Don't ignore white-coat and masked hypertension
- Cardiologist gets 10 years for performing unnecessary interventions
- CVD risks of HIV infection underestimated
- Michael Jackson dies of cardiac arrest
- CT-angiography-identified vulnerable plaque associated with higher risk of ACS
- Frequent migraine with aura linked to stroke, lower frequency with MI and revascularization
- Moderate wine, little meat, many vegetables may be key Mediterranean diet items linked to longer life
- TRANSFER AMI published: Finding the optimal window for PCI postlysis
- Novel processing technique "freezes" cardiac motion during PET imaging
- Intensive LDL lowering improves carotid plaque stability
- Wide variations in EP practice across Europe
- Case Study: A 41-Year-Old Woman Presented to the ER With an Altered Mental Status, Tachycardia, Tachypnea, and Petechial Rash
- MADIT-CRT results: CRT-D reduces mortality and morbidity in NYHA 1 or 2 HF
- PR-interval prolongation increases risk of atrial fibrillation and pacemaker implantation
- Heart-attack prevention bill, mandating coverage for CAD screening, passes quietly in Texas
- More details on arrhythmias associated with sleep apnea
- Similar success, survival at PCI centers with and without surgical backup: NCDR data in print
- Intensive smoking-cessation program can double quit rate in cardiac patients
- CV mortality and hospitalizations declining in Canada
- More patients at LDL targets, but improvement still needed
- ESC issues statement on driving restrictions for ICD patients
- "Natural" ED product recalled; contains PDE-5 inhibitor
- Psoriasis associated with all vascular disease
- CT angiography does not reliably predict functional significance of lesions
- Framingham analysis: Look beyond LVEF in heart-failure management
- EMEA issues warning on possible clopidogrel-PPI interaction, but is there really a problem?
- Uncertainty remains as to whether genetic testing for VTE improves outcomes
- New low-cost, solar-powered BP device for developing countries
- Early natriuretic-peptide level changes seen to predict late acute-HF outcomes
- A Portuguese success story: One nation begins to curb its salt intake
- FDA urges caution in interpreting study linking stimulants to increased risk for sudden death in children
- Published ATLAS ACS-TIMI 46 results for rivaroxaban pave the way for phase 3 trial
- NT-proBNP proposed for LVD screening in patients at high risk for heart failure
- Exercise training boosts benefits of cardiac resynchronization therapy
- Darusentan data encouraging but "very, very early"
- theheart.org editor wins NIHCM journalism award
- Red yeast rice reduces LDL-cholesterol levels in statin-intolerant patients
- DES "noninferior" to MIDCAB for isolated LAD disease, small study suggests
- HCTZ a "paltry" antihypertensive, with no effect on outcomes, new analysis suggests
- GLP-1 analog outperforms sulfonylurea in type 2 diabetes
- Proinflammatory and prothrombotic markers seen in obese kids with no other metabolic syndrome risk factors
- Some surprises in update to European hypertension guidelines?
- Chronic corticosteroid use a risk factor for CV events in kidney graft recipients
- Paclitaxel-eluting stents may be safe, effective in certain elderly patients
- Medtronic pacemaker advisory now a class-1 recall
- Beta-blocker benefit in SENIORS independent of LVEF
- More evidence links glitazones to broken bones
- Enrollment resumes for CHD chelation-therapy trial
- Health concerns real for the overweight, especially if other risk factors present, says AHA
- "Eco-Atkins" plant-based, low-carb diet appears to lower cholesterol
- Preoperative status predicts success of infrainguinal bypass for PAD
- Success, complication rates for ablation therapy of atrial fib are consistent in meta-analysis
- Genetic predisposition plus use of ACE-activity-lowering drugs may increase suicide risk in men
- A good night's sleep associated with reduced blood pressure
- Intensive glycemic control not directly linked to excess cardiovascular risk
- Proton-pump inhibitors blunt efficacy of clopidogrel in diabetics with coronary stents
- Simple steps can reduce radiation dose with CT angiography
- New data show that Lp(a) is a causal factor for MI, researchers say
- Pioglitazone slows progression of carotid atherosclerosis
- Once-weekly exenatide achieves better glycemic control than daily sitagliptin or pioglitazone
- Ray of hope for customizable-length DES
- LEAD 6: Greater A1C drop with liraglutide than exenatide in type 2 diabetes
- AHA urges exercise to cut CV risk in diabetics
- Milestone paper: First 5-year data on stem-cell treatment in AMI
- FDA approval requested for Crestor-Trilipix combo
- Half of strokes early after TIA occur within 24 hours
- No mortality, CV-event differences between revascularization and medical therapy in diabetics: BARI 2D
- Avandia on the RECORD: No "overall" CV risk increase, but trial remains controversial
- Newly minted FDA commissioner gets an earful of prasugrel
- Parathyroid hormone levels predict CV mortality in the community
- Hypertension well-controlled in medically complex patients
- Meta-analysis questions use of aspirin in primary prevention
- FDA rejects application of beta blocker intended for genotype-guided heart-failure therapy
- Rapid growth in infancy linked to cardiovascular and metabolic risk factors later in life
- PEPCAD-2 ISR drug-coated balloon study now published
- Six generic clopidogrel versions pass first EU marketing hurdle
- Periodontitis and CHD: First evidence of a genetic link
- AHA/ASA science advisory recommends use of tPA between three and 4.5 hours after stroke
- No benefit of compression stockings in DVT prevention after stroke
- Call to cardiac screen all family members of sudden-death victims
- APPRAISE with apixaban and STARR with rosiglitazone and ramipril published
- ICSS: Carotid endarterectomy superior to stenting, at least in the short term
- FDA gives go-ahead to second paclitaxel-eluting stent for small-diameter coronaries
- FDA puts rivaroxaban decision on hold, seeks further information
- PHIRST published, and tadalafil approved for pulmonary arterial hypertension
- Fit but huge, NFL players show normal array of CV risk factors
- Naproxen best NSAID for heart-disease patients
- FDA approves tolvaptan for hyponatremia
- SADHART: Increased mortality in severely depressed ACS patients
- Statin therapy after first stroke reduces recurrence and improves mortality
- Any delay in door-to-balloon time associated with increased in-hospital mortality
- DATE registry: Three months of clopidogrel for Endeavor? Plus, Xience SPIRIT V
- Same-day carotid stenting and CABG safe and feasible in patients with severe disease
- Give blood pressure drugs to all
- SYNTAX tool unveiled at EuroPCR: Now the trick is to use it
- MADIT-2 at eight years: Further ICD survival gains, signs of improved cost-effectiveness
- Intensive glucose control reduces MI and CHD-event risk, new meta-analysis shows
- Genotyping info now in US clopidogrel label
- Incremental updates from transcatheter-valve registries can scarcely keep up with physician interest
- More follow-up on the Watchman LAA closure device
- TIMACS published, supports early intervention in high-risk non-STEMI ACS
- DES in AMI: Some reassurances, more questions from TYPHOON and STRATEGY
- New HRS/EHRA recommendations for ablation of ventricular arrhythmias
- Chewable aspirin best for ACS: Small study supports guidelines
- Large meta-analysis links higher levels of cardiorespiratory fitness to lower risk of death and cardiovascular disease
- Intramyocardial bone-marrow injection for chronic ischemia
- The return of the reservoir DES: Nevo stent impresses against Taxus at six months
- Pooled five-year results for Endeavor support durability of TLR, low adverse events
- Eliminating cyclophilin A gene protects against abdominal aortic aneurysm
- US registry points to substantial risk from ICD, pacemaker replacement
- Obesity paradox probed in new review
- Antihypertensive use in pregnancy: No clear-cut answer on risk of congenital heart defects
- Subcutaneous ICD system detects and terminates induced ventricular fibrillation
- High, low estradiol levels linked to mortality in men with chronic systolic heart failure
- ATHENA data suggest dronedarone for AF is safe in stable heart failure
- Dr Eric Topol one of GQ magazine's "Rock Stars of Science"
- Budiodarone reduces atrial-fibrillation burden in phase 2 study
- DASH diet reduces risk of heart failure
- MI rates drop after decline in HRT use post-WHI
- Pulmonary vein isolation plus substrate ablation best for reducing AF
- ALTITUDE: Survival with primary-prevention ICDs better than ever in remotely monitored "real-world" population
- The obesity epidemic in the US is due solely to increased food intake
- No complications, no overheating with MRI-compatible pacemaker and leads
- HRS urges upgrades to process of recognition, reporting of ICD lead performance issues
- New HRS consensus statement on lead extraction sets volume benchmarks for operators
- No significant reduction of CV events with aspirin in peripheral artery disease
- New antiplatelet ticagrelor could challenge clopidogrel, prasugrel
- CHAMPION trials with cangrelor stopped for lack of efficacy
- Low fracture rate, clinical improvements with Zilver stent for peripheral artery disease
- Lower blood pressure, not the drug regimen, regresses left ventricular hypertrophy
- Delays to treatment similar for radial and femoral PCI in STEMI patients
- Risk-factor modification is goal of cardiac rehab program that emphasizes burning calories
- ACC, ASA, and AHA implore clinicians to enroll patients in PFO trials
- Device closure of PFO "tunnel" may offer advantages over double-disk occluders
- First hint of a benefit for statins in rheumatic valve disease
- New AHA/ASA guidelines on TIA management and telemedicine in acute stroke released
- Somatic depressive symptoms predict worse CVD outcomes in women
- Dual-acting receptor antagonist superior to ARB for treatment of hypertension
- New studies identify genetic variants associated with blood pressure and hypertension
- ACCOMPLISH: Systolic blood pressure with 24-hour monitoring no different in treatment arms
- Fix and ship: No mortality penalty when STEMI patients transferred back to referring hospitals post-PCI
- Stent studies hit print: DES positions fortified in SCAAR, HORIZONS-AMI, and Ontario registry
- Gene variants affecting response to clopidogrel not a factor with prasugrel
- Konstam offers new details on his role in Vioxx meta-analysis
- Return of the J-curve: TNT analysis shows that BP can be too low in CAD patients
- AMADEUS: Percutaneous mitral annuloplasty device shows promise at six months
- In brief: Biosite recalls cardiac marker test, FDA warns about Baxter sealant
- Stent thrombosis responsible for an increasing proportion of STEMI
- Most hypertension drugs, except ARBs, better than no treatment for CHD risk reduction
- Possible "class effect" for proton-pump inhibitors on top of clopidogrel therapy
- Blacks more likely to have AF than previously thought?
- No link between hypoglycemia and mortality or stroke/MI in diabetic AMI patients: DIGAMI-2 analysis
- Reperfusion markers at primary PCI seen to predict short-term arrhythmic risk
- Merck begins defense in Vioxx case in Australia
- Microalbuminuria predicts VTE in population-based study
- RECORD4 published: Rivaroxaban superior to enoxaparin in VTE prevention
- Family docs and internists mistakenly think they do fine treating high blood pressure
- CMS on warfarin-responsiveness genetic test: No Medicare coverage except within trials
Featured Clinical Tool
Pocket Guide:
National Guidelines and Tools for Cardiovascular Risk Reduction
Annual Symposium index
Save the Date! PCNA 16th Annual Symposium
Cardiovascular Risk Reduction: Leading the Way in Prevention
April 15-17, 2010 - Northwest Chicago, ILOrder